journal article·2021-02-12Open access

Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2

Yuan-Zhe Jin, Guang-Bin Zheng, Jae Hyup Lee, Shi-Huan Han

Biomaterials Research· Volume 25· Issue 1

Abstract

Abstract Background Autograft has been widely used in various orthopedic and dental surgery for its superior osteogenicity, osteoinductivity and osteoconductivity. But the available volume of the autograft is limited and the efficacy of it is highly affected by the condition of the patients. Therefore, growth factors such as Escherichia coli bone morphogenetic protein-2 (ErhBMP-2) has been widely used in some countries and regions with various carriers that could affect the effects of the growth factors. Demineralized bone matrix (DBM) has been widely used as a bone graft substitute and growth factor carrier, but its effect as a carrier of ErhBMP-2 was less investigated. Materials and methods Rat calvaria defect model was used in this study. We implanted ErhBMP-2 with DBM or hydroxyapatite (HA) as a carrier in 8 mm calvaria defect and compared their bone regeneration effect in 4th week and 8th week after implantation with micro-CT and histology. The data was analyzed with one-way ANOVA method with Bonferroni post-hoc analysis. Result The group with DBM as the carrier showed significantly higher bone volume and bone thickness than the groups with HA as the carrier in both weeks. And the histology sections showed less adipose tissue formed in the groups with DBM as the carrier. Conclusion DBM could be a better carrier for ErhBMP-2 than HA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Surgery, College of Medicine, Seoul National University, Seoul 03080, South Korea.

The First Hospital of Jilin University, Changchun City 130021, China.

Department of Orthopaedics, Taizhou Hospial of Zhejiang Province, Linhai 317000, Zhejiang, China.

Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, 39 Boramae Gil, Dongjak-Gu, Seoul 156-707, South Korea.

Department of Orthopaedic Surgery, Seoul National University, College of Medicine, Institute of Medical and Biological Engineering, Seoul National University Medical Research Centre, SMG-SNU Boramae Medical Centre, Boramae-ro 5-gil 20, Dongjak-gu, Seoul 07061, South Korea.

Department of Orthopedic Surgery, YanBian University Hospital, Yanji 133000, Jilin Province, China.

Funding

Daewoong Pharmaceutical

References (29)

Show source-provided references
1. 10.1186/s40824-019-0157-y10.1186/s40824-019-0157-y ↗
2. 10.1007/s00586010028610.1007/s005860100286 ↗
3. 10.4055/cios.2018.10.3.27110.4055/cios.2018.10.3.271 ↗
4. 10.2217/rme.12.110.2217/rme.12.1 ↗
5. 10.3390/ijms2001008310.3390/ijms20010083 ↗
6. 10.31616/asj.2018.12.6.101010.31616/asj.2018.12.6.1010 ↗
7. 10.1002/jbm.b.3359910.1002/jbm.b.33599 ↗
8. 10.1016/j.spinee.2017.06.02310.1016/j.spinee.2017.06.023 ↗
9. Jin YZ, Zheng GB. Escherichia coli BMP-2 showed comparable osteoinductivity with Chinese hamster ovary derived BMP-2 with demineralized bone matrix as carrier. 2019. p. 1–10.
10. 10.1097/ID.000000000000036410.1097/ID.0000000000000364 ↗
11. 10.1186/s40824-015-0039-x10.1186/s40824-015-0039-x ↗
12. 10.1007/s10856-013-4967-510.1007/s10856-013-4967-5 ↗
13. 10.1016/j.spinee.2012.01.01310.1016/j.spinee.2012.01.013 ↗
14. 10.1007/s40145-015-0155-z10.1007/s40145-015-0155-z ↗
15. 10.1016/j.spinee.2005.02.00610.1016/j.spinee.2005.02.006 ↗
16. 10.1089/ten.tea.2017.000510.1089/ten.tea.2017.0005 ↗
17. 10.1007/s10856-017-6007-310.1007/s10856-017-6007-3 ↗
18. 10.5312/wjo.v5.i1.3010.5312/wjo.v5.i1.30 ↗
19. 10.1002/jbm.a.3108510.1002/jbm.a.31085 ↗
20. Jin YZ Zheng GB Lee JH. Escherichia coli BMP-2 showed comparable osteoinductivity with Chinese hamster ovary derived BMP-2 with demineralized bone matrix as carrier. Growth Factors (Chur Switzerland). 2019;37(1-2):85-94.10.1080/08977194.2019.1596905 ↗
21. 10.1038/nprot.2012.11310.1038/nprot.2012.113 ↗
22. 10.4047/jap.2011.3.3.16110.4047/jap.2011.3.3.161 ↗
23. 10.1016/j.addr.2012.04.00210.1016/j.addr.2012.04.002 ↗
24. 10.3233/BME-2009-057310.3233/BME-2009-0573 ↗
25. 10.1002/jbm.a.3520710.1002/jbm.a.35207 ↗
26. 10.3858/emm.2012.44.5.03910.3858/emm.2012.44.5.039 ↗
27. 10.1016/j.addr.2012.06.00810.1016/j.addr.2012.06.008 ↗
28. 10.1242/dmm.03308410.1242/dmm.033084 ↗
29. 10.1007/s13770-013-1094-910.1007/s13770-013-1094-9 ↗